Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia
Author(s) -
Hanneke IJsselstijn,
Freek J. Zijlstra,
Jeanette P.M. Van Dijk,
J.C. de Jongste,
Dick Tibboel
Publication year - 1997
Publication title -
mediators of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.37
H-Index - 97
eISSN - 1466-1861
pISSN - 0962-9351
DOI - 10.1080/09629359791910
Subject(s) - congenital diaphragmatic hernia , medicine , prostacyclin , bronchoalveolar lavage , thromboxane , leukotriene d4 , prostaglandin , endocrinology , eicosanoid , pulmonary hypertension , lung , thromboxane a2 , leukotriene , vasodilation , asthma , fetus , pregnancy , arachidonic acid , biology , receptor , platelet , genetics , biochemistry , enzyme
Abnormal levels of pulmonary eicosanoids have been reported in infants with persistent pulmonary hypertension (PPH) and congenital diaphragmatic hernia (CDH). We hypothesized that a dysbalance of vasoconstrictive and vasodilatory eicosanoids is involved in PPH in CDH patients. The levels of several eicosanoids in lung homogenates and in bronchoalveolar lavage fluid of controls and rats with CDH were measured after caesarean section or spontaneous birth. In controls the concentration of the stable metabolite of prostacyclin (6-keto-PGF(1alpha)), thromboxane A(2) (TxB(2)), prostaglandin E(2) (PGE(2)), and leukotriene B(4) (LTB(4)) decreased after spontaneous birth. CDH pups showed respiratory insufficiency directly after birth. Their lungs had higher levels of 6- keto-PGF(1alpha), reflecting the pulmonary vasodilator prostacyclin (PGI(2)), than those of controls. We conclude that in CDH abnormal lung eicosanoid levels are present perinatally. The elevated levels of 6-keto-PGF(1alpha) in CDH may reflect a compensation mechanism for increased vascular resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom